Relation Between Glycemic Control and Retinal Microvascular Changes in Diabetic Patients Using OCTA
Retinopathy
1 other identifier
observational
50
0 countries
N/A
Brief Summary
An observational cross-sectional comparative study which will be conducted in the Department of Ophthalmology, Sohag University Hospital, Egypt to detect the relation between glycemic control and retinal microvascular changes in diabetic patients using OCTA
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 20, 2026
CompletedFirst Posted
Study publicly available on registry
July 24, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
July 24, 2026
July 1, 2026
6 months
July 20, 2026
July 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
OCT findings
OCTA images and data will be collected and analysed from the electronic medical reports for all patients to detect micro-vascular changes in the form of : 1. Vascular density ( superficial and deep plexuses )in square millimeters (mm²). 2. Foveal Avascular Zone ( FAZ ) in percentage
1 year
Study Arms (1)
This study will include 50 eyes of diabetic patients divided into: Group 1: 25 eyes of diabetic pati
This study will include 50 eyes of diabetic patients divided into: Group 1: 25 eyes of diabetic patients with controlled HbA1c Group 2: 25 eyes of diabetic patients with uncontrolled HbA1c,
Eligibility Criteria
50 eyes of diabetic patients with with diabetic retinopathy with controlled and uncontrolled HbA1c
You may qualify if:
- Diabetic patients with diabetic retinopathy with controlled and uncontrolled HbA1c
You may not qualify if:
- Media opacities affecting OCT imaging (corneal pathologies, dense cataracts, vitreous opacities, etc).
- Patients with any other retinal vascular diseases (retinal vein occlusion, central serrous chorioretinopathy, age-related macular degeneration, etc).
- Patients who have had previous intravitreal injections or Laser treatment.
- Patients who underwent previous vitreoretinal surgeries.
- Patients with recent history of undergoing cataract surgery.
- Patients with uncontrolled glaucoma or ocular inflammations (eg: vitritis).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Al Ahmady Al Samman, Professor
Faculty of Medicine, Sohag university
- STUDY DIRECTOR
Hany Mahmoud, Assist.Prof
Faculty of Medicine, Sohag university
Central Study Contacts
Sara Mahmoud, Lecturer
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Rediant of Opthalmology department
Study Record Dates
First Submitted
July 20, 2026
First Posted
July 24, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
February 1, 2027
Last Updated
July 24, 2026
Record last verified: 2026-07